latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
Forbes
Tue, 05/07/13 - 11:31 am
tags: Alkermes, AstraZeneca, clinical depression, Lundbeck, Merck, Novartis, Pfizer, Sanofi
Seeking Alpha
Fri, 07/27/12 - 11:55 am
TheStreet.com
Mon, 07/23/12 - 9:15 am
tags: Alexion, Alkermes, Amarin, Amgen, Amylin, AstraZeneca, BiogenIdec, Bristol-Myers Squibb, Celgene, drug approvals, earnings, Eli Lilly, Gilead, GSK, Horizon Pharma, Human Genome Sciences, InterMune, Merck, Progenics Pharmaceuticals, Questcor, Regeneron, Roche, Salix, Sanofi, United Therapeutics
Seeking Alpha
Wed, 07/18/12 - 12:27 pm
Seeking Alpha
Sun, 07/15/12 - 11:22 am
Seeking Alpha
Thu, 07/12/12 - 10:58 am
tags: Alkermes, Arena Pharmaceuticals, Orexigen, Questcor, Vivus
Seeking Alpha
Tue, 06/12/12 - 1:11 pm
tags: Alkermes, Arena Pharmaceuticals, Orexigen, Questcor, Vivus
Seeking Alpha
Mon, 06/11/12 - 11:26 am
Yahoo/Business Wire
Sat, 06/09/12 - 12:34 pm
tags: Alkermes, Amylin, Bydureon, diabetes, type 2 diabetes
Yahoo/Business Wire
Sat, 06/09/12 - 12:33 pm
tags: Alkermes, Amylin, Bydureon, diabetes, type 2 diabetes
Pharma Times, UK
Wed, 03/14/12 - 9:45 am
Seeking Alpha
Tue, 02/21/12 - 8:19 pm
Fierce Pharma
Mon, 01/30/12 - 5:00 pm
Last 30 twitter posts
-
Alkermes Plc (ALKS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new company profile report:... t.co/KkbDaoA0gi
-
Winners of the day: Dexcom $DXCM +8.7% Osiris $OSIR +6.6% Synergy 5.8% Ligand $LGND +4.8% Alkermes $ALKS +4.5% NPS $NPSP +4.07%
-
Alkermes ($ ALKS) has a shot at offering a new option for treating depression in patients who don't respond to..... t.co/wMtaEDXM2L
-
Alkermes ($ ALKS) has a shot at offering a new option for treating depression in patients who don't respond to..... t.co/IwgFNdfJC7
-
Alkermes gelato #fgf2013 @ Piazza Santa Maria Novella t.co/NiaZFzNc9Z
-
Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2013 t.co/4mgdY2kyrr
-
Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2013 t.co/SnHGnG46Gm
-
Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2013: DUBLIN--(BUSINESSWIRE)-- A... t.co/67KT0aokSR
-
Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2013 t.co/AnHQIyxA7S
-
Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2013 t.co/qsfYBn4AES
-
$ALKS Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Yea.. t.co/xgTF175lsn
-
Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2013 t.co/jrkaAs2iMK
-
Alkermes $ALKS Could Fall Through $30.62 Support Level ( t.co/1vJ694k9ly )
-
$ALKS Alkermes Plc Files 8-K : Departure of Directors or Certain Officers; Electio.. t.co/tX7Sg2gIgP
-
Alkermes Elects Nancy Wysenski to Board of Directors t.co/ZcnsJ32LZD
-
Alkermes Elects Nancy Wysenski to Board of Directors t.co/GtTBkGMQxA
-
Alkermes Elects Nancy Wysenski to Board of Directors t.co/myAjUC3lKp
-
Alkermes Elects Nancy Wysenski to Board of Directors t.co/4IpTrfzOW7
-
Alkermes Elects Nancy Wysenski to Board of Directors t.co/yxwwEIweZH
-
#Alkermes Plc : Alkermes Elects Nancy Wysenski to Board of Directors t.co/JJ7xi4adky $ALKS
-
Alkermes Elects Nancy Wysenski to Board of Directors t.co/vzKGrWTUDY
-
Alkermes Elects Nancy Wysenski to Board of Directors t.co/T9sQYA8kGq
-
$ALKS Alkermes Elects Nancy Wysenski to Board of Directors.. t.co/IArDVM5FlY
-
Sr./Lead Process Development Engineer-Crystallization - t.co/OnsAU8oKz0 #jobs #Alkermes #Waltham
-
@Alainlocatelli non c'è l'alkermes ma va bene, aggiudicata!
-
@Alainlocatelli uhm........ voglio del mascarpone e dell'alkermes sicuro.... :D
-
Freescale Semiconductor Ltd (NYSE:FSL) up by 4.44%, Alkermes Plc (NASDAQ ... t.co/DpdhMP19zM
-
Freescale Semiconductor Ltd (NYSE:FSL) up by 4.44%, Alkermes Plc (NASDAQ ... - GSPInsider t.co/2W8BEkkaHT
-
#semiconductor #news Freescale Semiconductor Ltd (NYSE:FSL) up by 4.44%, Alkermes Plc (NASDAQ ... - GSPInsider t.co/A4J2otdeOE
-
@martinapresta accetto il pandiespana OLE TORO!! solo se affogato e invaso da un'altamarea di alkermes. Ti adoro ma non troppo per la crema.
Latest Health Message Board Posts
... suicidal thoughts and behaviors, although the treatment will not include any boxed warnings. According to drugmaker Alkermes, about 10,000 patients a year currently use extended-release naltrexone to treat alcohol dependence, a treatment strategy approved ...
Posted by:
nygirl7
at
2010-10-13 05:00:00
on
medhelp.org
... one time Daily injection. Amlyn's Bydureon scheduled for approval in Oct by the FDA, is Basically the Byetta with technology from Alkermes. The base for both byetta and bydureon come from the sliva of the Gila Monster (go figure). Bydureon is scheduled for ...
Posted by:
PrettynPurple
at
2010-06-23 18:55:00
on
diabetesforums.com
... , others rise on Byetta news Bloomberg News SAN FRANCISCO � Amylin Pharmaceuticals Inc. and Waltham, Mass.-based Alkermes Inc. climbed in Nasdaq trading yesterday after regulators said they do not need more studies for a once-weekly version of the ... States and co-markets it with Amylin in the United States. The drug was developed by Amylin, and the longer-acting technology was developed by Alkermes.
Posted by:
mimmie2010
at
2010-03-16 05:46:00
on
diabetesforums.com